Pharmacogenomic (PGx) testing will help uncover your biological response to different medications.

CQuentia provides a comprehensive, industry-leading PGx test covering 43 genes and its 183 variants (mutation) addressing the response to over 24,000 medications and multiple conditions such as the patient’s risk to Malignant Hyperthermia, Pseudocholinesterase Deficiency, and the patient’s Thrombosis Profile.

CQuentia’s Pharmacogenomic testing program explore the patient’s unique individual genetic profile identifying how they will respond to the various medications used during and after surgery. CQuentia also defines when a patient has a genetic risk for malignant hyperthermia, a pseudocholinesterase deficiency or has a thrombosis risk. The combined view of medication efficacy and risk factors provides a greater level of patient detail that directly impacts the success of the surgical event.

We ensure that the results of our comprehensive pharmacogenomic (PGx) tests are made accessible at point-of-care. PGx guided medication management has shown to reduce narcotic use during surgery, decrease instances of post-operative side effects (such as nausea/vomiting) and improve post-operative pain scores.

Genes Being Tested and Interpreted at CQuentia
ABCB1CFTRDRD1HTR2CSLCO1B1
ABCG2COMTDRD2IFNL3TMPT
ADRA2ACYP1A2DRD3KCNIP1VKORC1
ADRB1 CYP2B6 EDN1LDLR
AGTCYP2C19F2MTHFR
APOECYP2D6F5NR1H3
BCHECYP2C9GNB3OPRM1
CACNA1CCYP3A4GRIK4RYR1
CACNA1S CYP3A5HTR1ASLC6A2
CES1DPYDHTR2ASLC6A4

If you would like to order a PGx Test